term
highli
pathogen
natur
remain
signific
need
defin
immun
patholog
sarscoronaviru
sarscov
infect
well
identifi
correl
immun
help
develop
vaccin
sever
coronavir
infect
use
sarscov
infectionreinfect
ferret
model
function
genom
approach
gain
insight
sar
immunopathogenesi
identifi
correl
immun
protect
sarscovchalleng
ferret
previous
infect
sarscov
immun
sar
viru
vaccin
identifi
gene
express
signatur
lung
ferret
associ
primari
immun
respons
sarscov
infect
ferret
receiv
ident
second
inoculum
acut
sarscov
infect
prompt
coordin
innat
immun
respons
domin
antivir
ifn
respons
gene
irg
express
reinfect
ferret
howev
lack
integr
express
irg
preval
acut
infect
express
specif
irg
also
absent
upon
challeng
ferret
immun
inactiv
al
oh
adjuv
whole
viru
sar
vaccin
candid
protect
sarscov
infect
lung
lack
ifnmedi
immun
enhanc
infect
ferret
previous
inocul
vaccin
sarscov
reveal
irg
correl
protect
immun
data
provid
insight
molecular
pathogenesi
sarscov
sarslikecov
infect
import
resourc
develop
cov
antivir
therapeut
vaccin
citat
cameron
mj
kelvin
aa
leon
aj
cameron
cm
ran
l
et
al
lack
innat
interferon
respons
sar
coronaviru
infect
vaccin
reinfect
ferret
model
plo
one
sever
acut
respiratori
syndrom
sar
diseas
hit
world
late
month
swiftli
spread
countri
infect
peopl
kill
etiolog
agent
sar
diseas
determin
coronaviru
cov
famili
largest
famili
singlestrand
positivesens
rna
genom
known
overal
mortal
rate
sar
corona
viru
sarscov
infect
rate
patient
prior
emerg
sar
viru
coronavirus
known
caus
mild
upperrespiratori
tract
diseas
human
contrast
sarscov
infect
caus
sever
diseas
lower
respiratori
tract
diseas
symptom
rang
flulik
viral
pneumonia
acut
respiratori
distress
syndrom
ard
fatal
outcom
viru
emerg
guangdong
provinc
china
cross
human
zoonot
reservoir
establish
theori
put
horsesho
bat
ultim
reservoir
sarscov
implic
palm
civet
intermedi
speci
pass
viru
human
aggress
public
health
intervent
strategi
credit
success
minim
sarscov
infect
rang
although
uncertain
public
health
strategi
would
suffici
contain
futur
sarscov
sarslikecov
outbreak
due
viru
evolut
importantli
coronavirus
propens
toward
frequent
hostshift
event
past
year
mani
cov
crossspeci
transmiss
incid
give
rise
new
anim
human
cov
base
diseas
coronavirus
infect
broad
rang
speci
lend
chanc
recombin
event
advent
new
cov
speci
moreov
coronavirus
chang
cell
type
tissu
host
speci
barrier
eas
typic
spike
protein
coronavirus
determin
host
infect
organ
sarscov
protein
show
signific
similar
aggress
class
viral
fusion
protein
influenza
viru
ha
env
simian
viru
ebola
viru
promiscu
coronavirus
coupl
tendenc
mutat
occur
give
reason
concern
anoth
cov
outbreak
like
highlight
need
continu
viral
surveil
forward
develop
cov
vaccin
strategi
therapeut
although
entri
sarscov
mammalian
cell
determin
facilit
convert
enzym
molecul
mechan
viru
evad
host
immun
respons
caus
gener
inflamm
increas
viral
burden
sever
lung
patholog
still
remain
signific
scientif
problem
previou
studi
shown
substanti
problem
potenti
cov
vaccin
vaccin
caus
diseas
exacerb
oppos
initi
immunolog
protect
recent
sever
group
describ
immunolog
respons
sarscov
infect
investig
use
mous
adapt
sarscov
mous
model
mouseadapt
sarscov
valuabl
anim
model
investig
immun
respons
possibl
therapeut
prophylact
strategi
sarscov
diseas
although
model
help
elucid
immunepatholog
event
sarscov
infect
protect
caveat
model
base
adapt
viru
wildtyp
sarscov
natur
occur
natur
caus
diseas
human
anim
although
death
observ
wt
sarscov
ferret
model
still
sever
advantag
use
model
perhap
equal
import
result
mous
model
compliment
find
ferret
model
vice
versa
specif
use
ferret
model
provid
sever
benefit
mention
ferret
suscept
wildtyp
sarscov
infect
strain
isol
human
furthermor
infect
respiratori
virus
includ
sarscov
ferret
display
mani
symptom
patholog
featur
seen
infect
human
ferret
human
similar
lung
physiolog
quantit
clinic
sign
display
ferret
includ
rise
core
bodi
temperatur
fever
nasal
discharg
sneez
runni
nose
weight
loss
investig
immun
respons
transcriptom
sarscov
pathogenesi
ferret
model
infect
unadapt
sarscov
subsequ
evalu
gene
express
signatur
induc
sarscov
reinfect
furthermor
ferret
immun
sarscov
vaccin
challeng
compar
immunolog
profil
sarscov
reinfect
anim
object
studi
identifi
immun
correl
protect
upon
reinfect
sarscov
ferret
provid
comprehens
profil
effect
nonpatholog
immun
respons
sarscov
challeng
follow
immun
inform
provid
foundat
direct
comparison
futur
sar
vaccin
studi
also
allow
us
determin
immun
mediat
respons
success
antivir
respons
previous
lack
repres
sarscov
infect
anim
model
limit
abil
uncov
immunopathogen
mechan
sar
imped
progress
vaccin
strategi
current
mous
model
sarscov
infect
describ
aspect
sarscov
pathogenesi
although
studi
util
mous
adapt
sar
viru
ferret
mustela
putoriu
furo
display
mani
symptom
patholog
featur
seen
sarscov
infect
human
suscept
unadatp
sarscov
strain
therefor
suggest
use
anim
model
studi
sarscov
infect
vaccin
strategi
ferret
assign
three
treatment
group
studi
mock
infect
control
group
b
singl
infect
group
c
group
infect
time
group
b
subsequ
reinfect
day
later
infect
group
innocul
intranas
tcid
tissu
cultur
infect
dose
sarscov
strain
mock
infect
anim
receiv
intranas
instil
vehicl
serumfre
cell
cultur
medium
sfm
ferret
monitor
clinic
sign
diseas
twice
daili
signific
symptom
observ
sarscov
infect
anim
sneez
observ
one
third
infect
ferret
day
postinfect
dpi
sneez
observ
ferret
control
group
group
c
time
postreinfect
neutralis
antibodi
titer
rose
baselin
dpi
maxim
postinfect
level
dpi
figur
specif
neutral
antibodi
singl
infect
group
b
increas
studi
day
peak
titer
day
neutral
antibodi
titer
fell
slightli
day
day
reinfect
increas
neutral
antibodi
directli
correl
decreas
viral
burden
lung
figur
four
week
postinfect
anim
group
c
reinfect
sarscov
second
spike
neutral
antibodi
level
seen
infect
phase
observ
within
week
neutral
antibodi
titer
remain
elev
approxim
two
week
diminish
end
studi
day
boost
antibodi
titer
may
contribut
lower
viral
burden
observ
reinfect
phase
day
second
peak
neutral
antibodi
titr
coincid
restrict
viral
replic
figur
neutral
antibodi
detect
mockinfect
control
group
strain
sarscov
replic
well
upper
respiratori
tract
data
shown
lung
within
first
week
postinfect
signific
viral
titer
background
detect
lung
rang
one
three
log
background
peak
viral
titer
observ
dpi
lung
figur
viral
titer
post
reinfect
day
gener
restrict
log
valu
figur
furthermor
investig
lung
histopatholog
follow
sarscov
infect
follow
sarscov
infectionreinfect
figur
ferret
lung
section
obtain
multipl
lung
lobe
post
primari
infect
post
secondari
infect
stain
hematoxylin
eosin
primari
sarscov
infect
produc
inflamm
appear
lung
immun
cell
primarili
surround
smalltomedium
bronchial
airway
day
follow
challeng
figur
b
ferret
receiv
infectionreinfect
larg
protect
lung
histopatholog
figur
c
taken
togeth
ferret
mount
effect
immun
respons
reinfect
sarscov
increas
neutral
antibodi
titr
restrict
viru
replic
diminish
clinic
symptom
less
lung
patholog
comparison
initi
infect
naiv
host
character
host
immun
respons
infect
reinfect
ferret
model
sarscov
pathogenesi
perform
gene
express
profil
lung
tissu
taken
necropsi
day
day
postinfect
dpi
day
day
postreinfect
dpr
three
ferret
time
point
profil
gene
express
signatur
associ
pulmonari
immunopatholog
sar
identifi
use
extract
analysi
differenti
gene
express
edg
differenti
time
cours
microarray
analysi
sarscov
infect
ferret
lung
sampl
heat
map
overview
contain
gene
identifi
significantli
differenti
express
across
time
point
classifi
ingenu
pathway
analysi
ipa
three
cluster
function
relat
gene
figur
irg
adapt
immun
gene
cluster
two
innat
immun
gene
cluster
signalingcompl
irg
cluster
strongli
express
ferret
lung
tissu
dpi
sarscov
rel
mock
primari
infect
group
convers
adapt
immun
respons
gene
cluster
enrich
gene
involv
antigen
process
present
highli
express
lung
sarscov
infect
ferret
dpi
sarscov
titr
increas
lung
prior
initi
peak
neutral
antibodi
titer
dpi
border
limit
detect
figur
upon
reinfect
sarscov
ferret
dpi
increas
gene
express
despit
anamnest
respons
neutral
antibodi
dpr
figur
analyz
three
cluster
function
relat
innat
immun
gene
detail
analysi
gene
express
profil
sarscov
infect
reinfect
show
decreas
irg
express
sarscovreinfect
compar
primari
infect
next
went
analys
express
profil
sar
infect
compar
reinfect
use
david
bioinformat
tool
use
perform
function
classif
differenti
express
gene
sarscov
primari
ferret
infect
robust
increas
number
upand
downregul
gene
day
infect
occur
day
differenti
gene
express
decreas
markedli
although
still
moder
level
day
gene
express
found
close
baselin
reinfect
moder
increas
gene
express
occur
maintain
longer
period
time
tabl
next
analyz
pathway
activ
profil
dpi
compar
dpr
correspond
peak
immun
activ
infect
tabl
dpi
gene
express
pattern
show
strong
activ
inflammationrel
gene
activ
mapk
jakstat
wnt
signal
pathway
tabl
togeth
pathway
particip
leukocyt
activ
migrat
infect
site
interestingli
among
upregul
gene
lysosom
degrad
among
kegg
pathway
significantli
enrich
fisher
exact
test
p
scenario
suggest
presenc
relev
phagocytosismedi
immun
without
trigger
signific
inflammatori
respons
taken
togeth
result
suggest
differenti
gene
express
profil
correspond
sar
infect
compar
reinfect
may
reflect
protect
host
immun
respons
neutral
antibodi
level
serum
determin
outlin
materi
method
section
invers
neutral
titr
repres
yaxi
vs
day
studi
xaxi
note
ferret
infect
studi
day
reinfect
ferret
also
innocul
studi
day
mock
infect
anim
receiv
intranas
instil
serumfre
media
studi
day
undetect
titr
valu
shown
repres
group
mean
ferret
per
group
error
bar
show
standard
deviat
complement
cascad
play
integr
part
innat
immun
label
pathogen
destruct
induc
leukocyt
migrat
lyse
bacteri
found
cluster
enrich
complement
system
gene
includ
bc
cfb
see
tabl
full
gene
name
significantli
upregul
first
week
post
infect
figur
quantit
rtpcr
qrtpcr
valid
shown
figur
interestingli
complement
gene
cluster
significantli
upregul
first
week
postreinfect
subsequ
markedli
downregul
follow
dpr
gene
three
complement
cascad
integr
dpi
determin
ingenu
pathway
analysi
ipa
includ
regul
figur
summari
complement
activ
correl
transit
innat
specif
immun
respons
clearanc
sarscov
primari
infect
strongli
regul
reinfect
proinflammatori
cytokin
known
function
variou
system
b
cell
develop
cell
activ
macrophag
prolifer
furthermor
signific
regul
fever
infect
found
express
seven
signalingassoci
gene
includ
jun
nfkbia
two
map
kinas
tabl
increas
ferret
lung
earli
dpi
dpi
figur
gene
increas
follow
reinfect
decreas
gene
express
confirm
qrtpcr
figur
context
upregul
molecul
dpi
peak
tnfa
signal
pathway
analyz
ipa
drawn
respect
pathway
figur
previou
analysi
host
immun
correl
pathogen
potenti
sarsinfect
individu
report
hyper
innat
ifn
ifn
respons
gene
irg
activ
could
identifi
acutelyinfect
sarscov
patient
persist
correl
ineffect
develop
adapt
immun
sever
clinic
cours
tabl
found
fifti
irg
significantli
upregul
ferret
lung
tissu
first
dpi
sarscov
rel
mockinfect
ferret
includ
mnda
gene
tabl
figur
qrtpcr
valid
perform
mnda
figur
key
upstream
mediat
integr
irg
gene
express
upon
phosphoryl
significantli
upregul
ferret
lung
acut
sarscov
infect
gene
express
confirm
qrtpcr
figur
two
ifninduc
chemokin
significantli
upregul
lung
dpi
sarscov
reinfect
tabl
figur
qrtpcr
valid
gene
express
shown
figur
interestingli
addit
edg
analysi
gene
identifi
significantli
differenti
express
across
time
point
perform
use
dpi
dpr
time
point
identifi
significantli
increas
gene
rel
dpi
one
irg
name
tabl
integr
express
innat
immun
gene
irg
ifnmedi
chemokin
lung
virem
sarscov
infect
ferret
therefor
reflect
antivir
respons
correl
acut
phase
sar
ferret
also
show
promis
evalu
candid
sar
vaccin
past
attempt
develop
cov
vaccin
unsuccess
mani
candid
vaccin
caus
diseas
exacerb
due
cellular
humor
immun
enhanc
via
antibodi
outer
envelop
protein
shown
immun
profil
correl
primari
sarscov
infect
ferret
furthermor
sarscov
reinfect
day
follow
primari
infect
show
signific
decreas
innat
adapt
immun
gene
activ
associ
immun
protect
therefor
comparison
next
profil
immun
respons
sarscov
vaccin
ferret
challeng
sarscov
determin
protect
molecular
signatur
could
induc
follow
vaccin
investig
vaccin
molecular
signatur
ferret
mockvaccin
control
vaccin
use
inacti
vate
whole
viru
sarscov
vaccin
candid
formul
without
al
oh
sar
fcpa
sar
fcp
respect
edg
microarray
analysi
preform
lung
rna
collect
day
post
sarscov
challeng
dpc
significantli
alter
gene
result
combin
time
cours
analysi
identifi
irg
ipa
figur
mani
also
identifi
infectionreinfect
experi
tabl
appli
twofold
mean
differ
biolog
filter
three
group
time
point
howev
found
irg
downregul
least
twofold
dpc
ferret
previous
immun
sar
fcpa
rel
mockvaccin
group
figur
irg
includ
qrtpcr
shown
figur
discuss
antioxid
enzym
role
mhc
class
antigen
process
see
tabl
full
gene
name
myxoviru
resist
potent
antivir
interestingli
tempor
express
pattern
irg
similar
amongst
sarscov
infectionreinfect
experi
irg
list
irg
adjuv
vaccinechalleng
experi
figur
data
show
downregul
earli
sarscov
challeng
regul
isg
gene
context
sar
vaccin
current
exist
pauciti
inform
surround
molecular
event
associ
protect
sarscov
infect
furthermor
due
evolutionari
promiscu
natur
sarscov
coronavirus
current
need
develop
vaccin
therapeut
strategi
human
mammal
time
cours
analysi
differenti
gene
express
lung
sarscov
infect
sarscov
reinfect
ferret
identifi
three
key
cluster
function
relat
gene
earli
dpi
express
signal
complement
ifn
respons
gene
follow
immedi
dpi
antigen
process
present
gene
express
correl
peak
sarscov
titr
lung
peak
neutral
antibodi
titer
respect
reinfect
ferret
sarscov
reiniti
organ
express
antivir
innat
immun
respons
gene
howev
adapt
immun
form
sarsspecif
antibodi
product
quickli
appear
dpr
correl
suggest
period
ifndriven
innat
antivir
respons
mediat
acut
sarscov
infect
specif
adapt
immun
respons
confer
protect
find
specif
imper
understand
sarscov
sarslikecov
infect
provid
comprehens
baselin
develop
cov
antivir
therapeut
vaccin
tailor
account
specif
ifn
respons
subsequ
antibodi
product
protect
role
complement
sarscov
pathogenesi
propos
howev
extent
complement
involv
sarscov
infect
unknown
studi
found
certain
complement
system
gene
significantli
upregul
first
week
post
infect
cfb
key
altern
complement
cascad
cleav
ba
bb
uniprot
bb
serin
proteas
combin
gener
convertas
first
target
recognit
protein
classic
complement
cascad
import
link
innat
adapt
immun
complex
activ
regul
form
complex
masp
proteas
previous
shown
upregul
sarscov
infect
patient
prior
either
recoveri
progress
sever
diseas
cleav
activ
produc
essenti
compon
convertas
classic
pathway
uniprot
initi
lectin
complement
cascad
via
masp
zymogen
eg
turn
cleav
interestingli
complement
signal
regul
also
upregul
dpi
shown
induc
human
bronchial
epitheli
cell
follow
sarscov
infect
vitro
vivo
well
associ
hyperimmun
activ
sarscov
infect
found
express
signalingassoci
gene
increas
ferret
lung
longer
period
time
complement
gene
dpi
dpi
gene
mainli
induc
receptor
signal
via
ra
pathway
gene
express
also
partial
depend
nfkb
activ
nfkbia
ikba
degrad
sinc
signal
drive
express
via
rasmap
kinas
cascad
activ
result
suggest
potenti
selfsustain
acut
phase
respons
occur
earli
sarscov
infect
reinfect
critic
ifnmedi
antivir
activ
jakstat
signal
prompt
widespread
transcript
activ
irg
resembl
result
pbmc
studi
acut
sarscov
infect
previou
result
sarscov
mous
model
promin
number
irg
upregul
ferret
lung
tissu
first
dpi
sarscov
infect
rel
mockinfect
ferret
induc
ifn
function
cell
costimul
viral
infect
induc
ifnc
role
antigen
present
uniprot
mnda
classic
antivir
irg
induc
mainli
type
ifn
uniprot
rapidli
induc
ifn
bind
upstream
regulatori
region
type
ifn
ifninduc
mhc
class
gene
convers
bind
interferon
consensu
sequenc
repress
irfmedi
gene
show
irfirg
gene
express
integr
acut
infect
nonfat
ferret
sarscov
infect
model
previous
identifi
dysregul
ifn
activ
sarscov
infect
patient
sever
clinic
cours
suggest
differ
balanc
irg
gene
signatur
affect
antivir
versu
proinflammatori
host
immun
respons
develop
phosphoryl
irg
transcript
invok
cellular
antivir
state
previous
report
upregul
sarscov
infect
inde
significantli
upregul
ferret
lung
acut
sarscov
infect
mice
suffer
wors
diseas
upon
sarscov
infect
greater
system
infect
viral
burden
lung
two
ifninduc
chemokin
significantli
upregul
lung
dpi
sarscov
infect
reinfect
protein
express
associ
earli
inflammatori
host
respons
murin
sarscov
infect
previous
demonstr
high
level
protein
present
plasma
sarscov
infect
patient
earli
ill
quickli
return
baselin
level
patient
quickli
recov
sever
case
sarscov
infect
howev
level
remain
significantli
elev
durat
patient
infect
interestingli
known
irg
significantli
increas
follow
reinfect
antivir
ubiquitinlik
modifi
conjug
type
ifn
stimul
also
antivir
deriv
shown
prefer
substrat
deubiquitin
activ
sarscov
papainlik
proteas
express
wide
varieti
lymphoid
cell
tissu
target
may
therefor
repres
uniqu
innat
immun
correl
influenc
tissu
viral
load
may
particip
ifnmedi
transit
innat
adapt
immun
collect
mark
express
ifnmedi
respons
lung
virem
sarscov
infect
ferret
reinfect
ferret
assert
proinflammatori
ifn
respons
complement
acut
phase
sar
resolut
irg
activ
associ
prime
anamnest
respons
neutral
sarscov
reinfect
without
reiniti
acut
inflamm
although
import
mention
lack
upregul
follow
second
infect
may
due
low
viru
replic
level
secondari
infect
presenc
low
immun
stimul
reinfect
group
probabl
associ
margin
viral
replic
also
analysi
gene
express
profil
suggest
scenario
limit
immun
stimul
without
promin
particip
suppressor
gene
gener
lack
ifnmedi
immun
respons
ferret
reinfect
sarscov
suggest
sar
vaccinechalleng
experi
would
reveal
addit
immun
correl
immun
microarray
analysi
sarscov
challeng
ferret
lung
without
previou
immun
use
al
oh
adjuv
inactiv
whole
viru
sarscov
vaccin
candid
reveal
downregul
irg
moreov
four
irg
express
common
sarscov
infectionreinfect
experi
irg
select
abrog
express
irg
sar
fcpa
vaccin
sarscov
challeng
ferret
reflect
infectionreinfect
result
demonstr
lack
irg
induct
upon
reinfect
express
gene
earli
natur
cours
infect
suggest
irg
indic
earli
stage
sarscov
diseas
neither
reinfect
sar
vaccinationchalleng
provid
evid
irg
biomark
immun
respons
capabl
suppress
sarscov
challeng
importantli
focu
studi
gene
express
protein
analysi
would
valuabl
addit
futur
experi
furthermor
measur
sarscov
viral
rna
level
sarscov
challeng
mock
sar
fcp
sar
fcpavaccin
ferret
lung
pcr
mockvaccin
ferret
pcrposit
sarscov
dpi
one
sar
fcpvaccin
ferret
posit
dpi
sar
fcpavaccin
ferret
pcrposit
sarscov
time
concern
regard
immun
enhanc
aros
immun
ferret
recombin
modifi
vaccinia
ankara
rmva
express
sarscov
spike
induc
strong
inflamm
hepat
later
attribut
rmva
express
sarscov
antigen
recent
formalininactiv
wholeviru
adenovirusbas
sarscov
vaccin
candid
shown
promis
reduc
pneumonia
sarscov
challeng
ferret
interestingli
immun
enhanc
seen
mice
vaccin
al
oh
non
tabl
express
select
significantli
chang
gene
time
sarscov
infectedreinfect
ferret
lung
adjuv
inactiv
sarscov
whole
viru
candid
vaccin
furthermor
vaccin
strategi
coronavirus
age
mous
model
also
investig
found
wild
type
vrp
venezuelan
equin
enceph
viru
replicon
particl
vaccin
protect
anim
challeng
ifnmedi
immun
enhanc
note
ferret
sarscov
infectionreinfect
model
previous
report
increas
neutral
antibodi
titer
sarscov
reinfect
correl
immun
protect
one
caveat
due
larg
natur
studi
absenc
alum
control
group
would
import
futur
investig
gene
regul
alum
treatment
alon
taken
togeth
studi
given
insight
molecular
event
follow
sarscov
infect
well
identifi
imper
signatur
immunolog
protect
sarscov
reinfect
vaccin
model
specif
ferret
model
sarscov
infect
show
two
step
tempor
paradigm
host
immun
respons
lung
sarscov
infect
ferret
character
earli
innat
immun
respons
robust
ifn
chemokin
gene
express
follow
adapt
immun
like
elicit
local
antisarscov
antibodi
protect
immun
respons
likewis
lack
repeat
robust
innat
immun
respons
ferret
reinfect
sarscov
suggest
postreinfect
gene
signatur
may
reveal
immun
correl
relat
success
immun
may
appli
futur
use
ferret
model
sar
infect
vaccin
strategi
thu
identifi
irg
potenti
invers
correl
immun
acut
sarscov
infect
versu
reinfect
sarscov
vaccin
versu
challeng
dataset
serv
resourc
human
sarscov
vaccin
candid
trial
model
vaccin
efficaci
popul
risk
sever
outcom
work
anim
conduct
strict
accord
institut
anim
care
use
committe
iacuc
guidelin
southern
research
institut
sri
lovelac
respiratori
research
institut
llri
sri
ferret
studi
approv
southern
research
institut
institut
anim
care
use
committe
southern
research
institut
veterinari
medicin
task
monitor
support
anim
experi
research
conduct
complianc
anim
welfar
act
feder
statut
regul
relat
anim
experi
involv
anim
adher
principl
state
guid
care
use
laboratori
anim
nation
research
council
facil
research
conduct
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
llri
anim
work
review
approv
lrri
institut
anim
care
use
committe
protocol
number
work
involv
infecti
agent
review
lrri
infecti
agent
committe
approv
infect
sampl
collect
perform
isofluoran
anesthesia
effort
made
minim
suffer
sarscov
amplifi
vero
cell
atcc
vero
crl
southern
research
institut
facil
describ
sarscov
strain
use
vaccin
prepar
cdc
strain
influenzafre
castrat
descent
male
fitch
ferret
mustela
putoriu
furo
week
age
purchas
tripl
f
farm
sayr
pa
infectionreinfect
ferret
randomli
assign
group
mock
primari
infect
n
primari
infect
n
mock
infectionreinfect
n
infectionreinfect
primari
secondari
inocul
n
day
group
two
four
ferret
anesthet
receiv
ml
serumfre
medium
contain
sarscov
per
nare
total
dose
tcid
dpi
ie
dpr
group
four
ferret
inocul
tcid
sarscov
mock
group
receiv
ml
serumfre
medium
three
group
one
two
ferret
sacrif
dpi
three
group
three
four
ferret
sacrif
dpr
vaccinechalleng
ferret
assign
group
mockvaccin
ferret
receiv
poloxam
baxter
product
specif
inocul
tcid
sarscov
occur
day
post
primari
vaccin
boost
deliv
two
week
prior
infect
six
ferret
group
one
two
three
sacrif
dpc
mock
vaccinechalleng
ferret
sacrif
dpc
procedur
accord
nrc
guid
care
use
laboratori
anim
anim
welfar
act
cdcnih
biosafeti
microbiolog
biomed
laboratori
anim
experi
conduct
regist
facil
lovelac
respiratori
research
institut
neutral
test
serum
tcid
quantif
sarscov
lung
tissu
suspens
perform
describ
viru
titr
express
tcid
unit
u
g
lower
limit
detect
tcid
ug
rtpcr
detect
within
cycl
sarscov
perform
isol
lung
rna
previous
describ
use
primer
total
rna
lung
prepar
microarray
analysi
describ
well
microarray
dataset
preprocess
normal
appropri
mock
dataset
rna
qualiti
one
infectionreinfect
group
four
ferret
dpr
lung
insuffici
array
affymetrix
genechip
canin
genom
array
affymetrix
santa
clara
ca
use
assess
ferretlik
gene
express
previous
establish
infectionreinfect
edg
use
identifi
significantli
differenti
express
gene
time
point
group
two
four
dpi
dpr
use
dpi
mock
baselin
vaccinechalleng
edg
use
identifi
significantli
differenti
express
gene
group
one
two
three
use
dpc
group
dataset
baselin
result
combin
hierarch
cluster
function
pathway
analysi
ipa
ingenu
system
redwood
citi
ca
gene
annot
includ
univers
protein
resourc
uniprot
url
wwwexpasyorguniprot
perform
previous
describ
dataset
avail
ncbi
gene
express
omnibu
day
pi
anim
euthan
upper
lower
left
lobe
lung
tissu
harvest
formalinfix
perfus
follow
paraffin
embed
section
tissu
slide
stain
hematoxylin
eosin
histopatholog
assess
microarray
analysi
use
edg
time
cours
model
p
q
signific
fals
discoveri
rate
respect
chang
least
one
time
point
figur
qrtpcr
valid
microarray
analysi
ferret
lung
infect
reinfect
sarscov
vaccin
sarscov
infect
qrtpcr
analysi
gene
express
lung
tissu
ferret
infect
reinfect
sarscov
aj
qrtpcr
analysi
express
lung
tissu
sar
vaccinatedchalleng
ferret
valu
shown
repres
group
mean
mrna
level
indic
time
point
rel
mean
mrna
level
appropri
mock
anim
dpi
aj
dpc
k
analys
perform
triplic
group
mean
repres
data
ferret
dpi
day
postinfect
dpr
day
postreinfect
dpc
day
postchalleng
error
bar
repres
standard
error
p
student
ttest
differ
mock
nonsignific
differ
mock
tif
tabl
gene
significantli
chang
time
sarscov
infect
ferret
lung
follow
reinfect
doc
